Navigation Links
Alpha and Omega Gene Therapy Eye Cream's Scientific Blend Removes Years of Damage
Date:12/19/2013

PHILADELPHIA, Dec. 19, 2013 /PRNewswire/ -- E'Shee Clinical Esthetic announced the launch of a new eye cream product that is designed to target wrinkles, sagging skin, dark circles and puffiness. But, unlike other eye creams, this Alpha and Omega gene therapy eye cream is a scientifically-advanced blend of innovative ingredients.       

(Photo: http://photos.prnewswire.com/prnh/20131219/LA36083)

"Supremely-advanced restoration and care for the eyes and lips is what this product delivers," Nataly Giter, founder, E'shee Clinical Esthetic, says.  

E'shee's eye cream has a light creamy texture and includes ingredients such as patented aFGF (acidic fibroblast growth factor), far-infrared powder and Botox-like peptides. It's designed for the most delicate facial skin and works to remove years and years of skin damage and negligence.

aFGF is a bioengineered growth factor identical to the natural growth factor found in the human body and can provide fast, skin-repairing effects while dramatically speeding up the skin-renewal process. And, far infrared powder, produced from natural elements, can absorb outside heat energy and then release it. It recharges aging or dying cells which may explain why a far infrared ray with this healing wavelength is called "life light."

In addition to the usual benefits of fine line disappearance, deep wrinkle reduction and firmer and healthier skin, gene therapy eye cream users will also realize better texture; rebuild extra cellular matrix and restore its function; and reduce puffiness through improved blood circulation and toxin removal.

Alpha and Omega gene therapy cream also works to reduce redness caused by rosacea; helps to repair broken capillaries; and can help to heal scar tissue resulting from burns or acne.

"Stronger and improved skin is typically seen within 28 days," Giter says.

E'Shee Clinical Esthetic recommends this gene therapy eye cream for all skin types and ages. It's a non-greasy and fast-absorbing formula that does not clog pores.

About E'shee Clinical Esthetic:

E'shee was launched in 2009 by Nataly Giter, a hands-on skin care professional with more than 20 years of experience. Through research and practical experience, she learned about the most effective ingredients for advanced skin care and became associated with Dr. Chiu, a professor from Ohio University and the first global pioneer to clone the human FGF-1 gene.

Together, with their combined connections to industry professionals, they used FGF-1 to create an extraordinary anti-aging product line, using 99 percent pure FGF-1 peptide - the best quality available outside of the human body.

For more information on E'shee Clinical Esthetic, visit: www.esheeesthetic.com or http://www.esheeesthetic.com/wordpress/.

- Photo 72dpi: http://send2press.com/mediaboom/13-1218-eshee-eyecream_400x300.jpg

- Photo Caption: Alpha and Omega Gene Therapy Eye Cream.

This release was issued through Send2Press(R), a unit of Neotrope(R). For more information, visit Send2Press Press Release Distribution at http://www.Send2Press.com


'/>"/>
SOURCE E'shee Clinical Esthetic
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Alpha Imaging Acquires Tristar Midatlantic Imaging
2. U.S. Gastroenterologists Have Increased Their TNF-alpha Inhibitor Use Since 2012, Especially for AbbVies Humira, as a Result of Its Recent Approval in Ulcerative Colitis
3. The Michael J. Fox Foundation Leads Charge to Develop Alpha-Synuclein PET Tracer to Image Parkinsons Disease Biomarker
4. Harrisvaccines, Inc. Secures Exclusive Rights From AlphaVax, Inc. to Develop RNA Particle Vaccines for All Diseases in Companion Animals
5. Uroplasty To Participate In The Craig-Hallum Alpha Select Conference
6. IRIDEX to Present at Craig-Hallum 4th Annual Alpha Select Conference
7. Cardica To Present At Craig-Hallum Alpha Select Conference
8. Carolus Therapeutics and The Alpha-1 Project Collaborate to Validate CT-2009 Target as Important in Human Disease
9. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
10. CoMentis and Anvyl Announce Formation of Alpharmagen, a Joint Venture to explore Nicotinic Modulators
11. ImmunGene and Collaborators Report Positive Results in Pre-clinical Studies of Novel Anti-CD20 Antibody-Interferon Alpha Fusion Protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... 17, 2017  Bayer announced today that the latest ... presented at the 53 rd Annual Meeting of ... June 2-6 in Chicago . ... prostate, colorectal, liver and thyroid cancers, as well as ... II CHRONOS-1 trial of copanlisib in patients with relapsed ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/11/2017)... 11, 2017  Thornhill Research Inc. ( ... an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by ... Commercial Corporation (CCC) ( Ottawa, Ontario, Canada ... administer general anesthesia to patients requiring emergency medical ... US Marine Corps have been a longtime partner ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... May 26, 2017 , ... Somnoware, a leading provider of ... with its Somnoware Sleep Device Interface (SDI). Somnoware SDI is a sleep device ... this platform, initializing devices and importing studies are just one-click operations. This plugin ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... is sharing bold recipes for Memorial Day entertaining that are sure to satisfy ... “Boar’s Head fresh sliced meats and cheeses featured in these refreshingly balanced recipes ...
(Date:5/26/2017)... BOSTON, MA (PRWEB) , ... May 26, 2017 , ... ... Care Act (AHCA), which narrowly passed the U.S. House on May 4, would result ... would be expected under continued implementation of the 2010 Patient Protection and Affordable Care ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... week that is focusing on the Peace Agreements being discussed by President Donald Trump ... in a race to try to speed up peace talks in the continuous battle ...
(Date:5/26/2017)... ... ... Rob Lowe acts as host and helps educate and inform the public using ... Viewers can reconnect with America as it explores some of the best places to ... for an inventive new place for a family vacation, and have discovered hiking. Many ...
Breaking Medicine News(10 mins):